Renée Richards v. USTA: The 1977 Sex-Test Ruling

Timeline

1. 1975Richards undergoes sex reassignment surgery at age 41.
2. Jul–Aug 1976After she applies to the U.S. Open, the USTA introduces a sex-chromatin test for women.
3. 1976USTA and WTA withdraw sanction from a tournament that invites Richards; most players withdraw.
4. Aug 16, 1977Justice Alfred Ascione rules for Richards under the New York Human Rights Law.
5. Aug–Sep 1977Richards plays the U.S. Open and reaches the women's doubles final.
6. 1981Richards retires from professional tennis and returns to medicine.

The ethical issues

• Defining eligibility: chromosomes, anatomy, hormones or legal identity.
• Fairness: whether past development as a male confers lasting advantage.
• Discrimination: a test introduced specifically in response to one athlete.
• Role of courts: whether judges or sports bodies should set eligibility rules.
• Privacy and dignity in eligibility processes.

Stakeholders

Stakeholder	Interests & obligations
Renée Richards	The right to compete as a woman.
Women players	Fair competition and their own opportunities.
USTA and WTA	Authority to set eligibility rules.
Transgender athletes	Precedent and inclusion.
Tournament organizers	Running events amid controversy.
Medical experts	Accurate science in eligibility rules.

The case

Before 1975, Richard Raskind was an ophthalmologist and an accomplished amateur tennis player. In 1974, he was ranked 13th nationally in men’s 35-and-over tennis.^[2] In 1975, at 41, Raskind underwent sex reassignment surgery and became Renée Richards. She moved to California and began playing in women’s tournaments.^[1][2]

Background

Richards’s tennis background was substantial before transition. She captained the men’s team at Yale, graduating in 1955. She went on to medical school at the University of Rochester and specialized in ophthalmology.^[1] While training as a doctor in the U.S. Navy, she won the singles and doubles at the All Navy Championship with a left-handed serve.^[1]

The South Orange event was the Tennis Week Open, run by her long-time friend Gene Scott. After the USTA and WTA withdrew their sanction and organized a rival tournament, 25 of the 32 players withdrew.^[1] The U.S. Open Committee’s stated position was that “there is competitive advantage for a male who has undergone a sex change surgery as a result of physical training and development as a male.”^[1] Sports Illustrated described reactions to Richards as “varying from astonishment to suspicion, sympathy, resentment, and more often than not, utter confusion.”^[1]

The rules and governance

The legal question was narrow. Justice Ascione did not rule on the general fairness of transgender women competing. He ruled that using a single chromosome test as the sole criterion, adopted to exclude one person, violated New York’s Human Rights Law.^[2] In his ruling he wrote that the defendants’ “unfounded fears and misconceptions” had to “give way to the overwhelming medical evidence that this person is now female.”^[2] The court accepted that the test could be one factor in determining eligibility, alongside medical evidence about her physiology.^[2]

The ruling did not settle rules elsewhere. Without the test, Richards had been unable to play the 1976 U.S. Open, Wimbledon or the Italian Open.^[1] Her case remains a reference point for later debates over chromosome screening and eligibility.^[1][6]

The test

In 1976, after Richards won a women’s tournament in La Jolla, her history became public. When tournament director Gene Scott invited her to a professional event in New Jersey, the USTA and the Women’s Tennis Association withdrew their sanction and organized a rival event; most of the field withdrew.^[1]

Richards applied to play in the 1976 U.S. Open. The USTA responded by requiring women entrants to take a sex-chromatin test, known as the Barr body test, which detects a second X chromosome in cells from a cheek swab. It had never required such a test in its 95-year history. The court later found that this decision was “a direct result” of Richards’s application.^[2] The USTA said its concern was fairness. It argued that someone who had developed as a male would have a competitive advantage, and that Olympic-style sex tests were a reasonable safeguard.^[2]

The ruling

Richards refused the test and sued the USTA, the U.S. Open Committee and the WTA. On August 16, 1977, Justice Alfred Ascione of the New York Supreme Court granted a preliminary injunction. He held that requiring Richards to pass the Barr body test as the only measure was “grossly unfair, discriminatory and inequitable” and violated New York’s Human Rights Law. The test could be one factor, but not the sole criterion.^[2][3] Richards submitted affidavits from medical experts and from Billie Jean King, who said Richards did not have “physical superiority or strength” over women players. The judge found that the USTA had “knowingly instituted this test for the sole purpose of preventing plaintiff from participating.”^[2]

The opinion set out the competing medical evidence. The test, the court noted, had first been used by the International Olympic Committee at the 1968 Olympics.^[2] A Stanford medicine professor who submitted an affidavit for the defendants, without examining Richards, said that after male puberty, neither surgery nor estrogen treatment could change an individual’s height or skeletal structure, and that the reduction in strength from treatment was “partial” and depended on continued estrogen use.^[2] Richards’s surgeon stated that her hormone treatment and surgery had reduced her muscle mass, and that her “muscle development, weight, height and physique fit within the female norm.” The court recorded that she was six feet two inches tall and weighed 147 pounds.^[2] Justice Ascione took a narrow view of why sex tests existed at all: “The only justification for using a sex determination test in athletic competition is to prevent fraud, i.e., men masquerading as women, competing against women.” He added that the court was “not striking down the Barr body test,” which appeared to be “a recognized and acceptable tool for determining sex,” but that it “should not be the sole criterion” where the circumstances warranted other factors.^[2]

Career and later views

Richards played in the 1977 U.S. Open. She reached the women’s doubles final and played professionally until 1981, when she was 47. Her highest ranking was 20th, in 1979. She later coached Martina Navratilova to two Wimbledon titles and returned to medicine.^[1]

Years later, Richards expressed ambivalence about her legacy. She said that if she had transitioned at 22 and joined the tour at 24, “no genetic woman in the world would have been able to come close to me.”^[1][5]

Aftermath

In the 1977 U.S. Open, Richards lost to Virginia Wade in the first round of singles on September 1. In doubles, she and Betty Ann Stuart reached the final, losing to Martina Navratilova and Betty Stöve.^[1] She later won the 35-and-over singles title at the Open, defeating Nancy Richey in 1979, and twice reached the mixed doubles semifinals with Ilie Năstase.^[1] She coached Navratilova to Wimbledon titles in 1982 and 1983.^[1] She later became surgeon director of ophthalmology at the Manhattan Eye, Ear and Throat Hospital.^[1] She published two autobiographies: Second Serve in 1983, and No Way Renée in 2007, in which she expressed regret about the kind of fame that came with being transgender, though not about transitioning itself.^[1] In 2013 she was in the first class inducted into the National Gay and Lesbian Sports Hall of Fame.^[1]

Looking back in a 2015 BBC interview, Richards said her acceptance on the tour came slowly. “I had death threats, I had people that hated me,” she said, and “there were some players who would walk off the court when I played them or they wouldn’t play me at all.” She said many former opponents later became friends.^[4] She was barred from tournaments in Europe. She described herself as “a reluctant pioneer, for all of the disenfranchised groups in the world, no matter whether they were transgender, gay or lesbian.”^[4]

The core dilemma

The USTA introduced a chromosome test to exclude one player, and the court found that unfair. Yet the question behind it, whether people who went through male development should compete in women’s sport, has only grown. Was the 1977 ruling a victory for fairness and dignity, or did it avoid the hardest question?

Competing values

• Inclusion vs. competitive fairness: the right to compete against the integrity of the women’s category.
• Individual assessment vs. bright-line rules: case-by-case judgment against simple tests.
• Dignity vs. verification: respect for identity against checks on eligibility.
• Courts vs. sports bodies: who should decide.

Strongest arguments

For the ruling: the USTA created a test to target one person, and relied on a single chromosomal marker that medicine itself questioned. Richards, in her forties, was not dominant on the tour.

For the USTA’s concern: Richards’s own later comments suggest that male development can confer lasting advantages. Sports bodies need workable eligibility rules that protect the women’s category.

Applying the frameworks

Rights

A rights lens frames Richards’s claim as protection against discrimination and against being singled out by a rule designed to exclude her. It asks how sport balances individual rights with category rules, and what due process requires when eligibility is challenged.

Justice

A justice lens asks what fair competition requires in the women’s category, and whether a single test or an individualized assessment better balances inclusion and fairness. It notes that her performance on court was relevant evidence.

Kantian (duty)

A Kantian lens asks whether the USTA treated Richards with respect as a person, or used a test as a means to exclude her. It also asks whether rules can be universal while still allowing for individual circumstances.

Walk it through: the Simple Decision Model

1. Spot the issue. You are a USTA official in 1976 when a transgender woman who has had surgery applies to play in the women’s draw at the U.S. Open. The stakeholders include the applicant, other women players, the WTA, tournament organizers, sponsors and fans. The codes in play are the tournament’s eligibility rules and civil rights law.
2. Gather facts. What do medical experts say about her physiology? What evidence exists of a competitive advantage? What rules have applied before?
3. Test options. Options: (a) introduce a new chromosome test for all women; (b) assess eligibility individually using medical evidence; (c) admit her and review the policy after the tournament. Weigh fairness concerns against her rights and the risk of a rule aimed at one person.
4. Check codes and law. Would the rule withstand a legal challenge? Would you accept it if it were applied to you?
5. Decide and document. Record the evidence and reasoning.
6. Communicate and follow up. Communicate the decision and the process for review respectfully, and protect the privacy of every player.

What’s settled and what’s contested

• Settled: the 1977 ruling and its reasoning; Richards’s professional record.
• Contested: what eligibility criteria are fair; how much weight her later views should carry.

Why this case matters

Richards’s case was the first major legal test of sex eligibility in professional sport. Its questions about chromosomes, fairness and dignity remain at the center of today’s debates.

Key terms

Distributive justice

Fairness in how scarce opportunities, resources, benefits and burdens are shared.

Due process

Fair procedures before a sanction: notice, a chance to respond, an impartial decision-maker and a right of appeal.

Consent and autonomy

Whether people have agreed freely and with full information, and whether their right to make their own choices is respected.

Legal but unethical

Law sets out what can be punished; ethics asks what is right. Compliance is a minimum, so an action can be lawful and still wrong.

Definitions from the Ethics Cases glossary.

Discussion questions

1. The USTA introduced the chromosome test only after Richards applied. Does that affect whether the rule was fair?
2. The court said the test could not be the sole criterion and that other factors must be considered. What factors should define eligibility for women's sport?
3. Richards later said she believed her past gave her an advantage, especially if she had transitioned younger. How should her view affect today's debates, if at all?
4. Should eligibility questions be decided by courts, legislatures or sports bodies?
5. How does Richards's case compare with the 2026 Supreme Court ruling on state laws for school sports?

Sources

1. Renée Richards — Wikipedia
2. Richards v. United States Tennis Ass'n, 93 Misc. 2d 713 (N.Y. Sup. Ct. 1977) — OpenJurist
3. Renee Richards Ruled Eligible for U.S. Open — The New York Times
4. Tennis's reluctant transgender pioneer — BBC News
5. The Lady Regrets — The New York Times
6. From tennis outcast to trans pioneer — BBC Sport